About this document
Use of Real-World Evidence in Economic Assessments of Pharmaceuticals in The United States by cristobaljoa11 is a document available to read on EtoBox.
This study assesses the use of real-world evidence (RWE) in economic assessments of pharmaceuticals by the Institute for Clinical and Economic Review (ICER) in the U.S. It found that RWE is increasingly utilized, with about a third of model inputs informed by RWE, primarily for disease progression and healthcare costs, though its role in drug effectiveness remains limited. The research highlights a trend towards greater incorporation of RWE in economic evaluations, reflecting its growing importance in healt
- Author
- cristobaljoa11
- Language
- EN